glp 1 for alcohol use disorder GLP-1s Reduce Heavy Drinking Days in Patients With Obesity, The Role of Glucagon-Like Peptide-1

Mielko KA, Jaboski SJ, Milczewska J, Sands D, ukaszewicz M, Mynarz P

Clinical efficacy of once-weekly glucagonlike peptide-1 receptor agonists in patients with type 2 diabetes

[I prescribe GLP-1s to many patients because] they are shown to reduce the risk of dying from heart disease by up to 20% depending on the population

By injecting B12 directly into the bloodstream, we can quickly and efficiently restore healthy levels, helping to boost energy, improve concentration, and enhance overall well-being for our patients

Extended data Supplementary information Rights and permissions Springer Nature or its licensor (e.g

Additionally, patients should be aware of potential side effects and drug interactions